433 related articles for article (PubMed ID: 29314763)
1. Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness.
Palmer EE; Schofield D; Shrestha R; Kandula T; Macintosh R; Lawson JA; Andrews I; Sampaio H; Johnson AM; Farrar MA; Cardamone M; Mowat D; Elakis G; Lo W; Zhu Y; Ying K; Morris P; Tao J; Dias KR; Buckley M; Dinger ME; Cowley MJ; Roscioli T; Kirk EP; Bye A; Sachdev RK
Mol Genet Genomic Med; 2018 Mar; 6(2):186-199. PubMed ID: 29314763
[TBL] [Abstract][Full Text] [Related]
2. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.
Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA
PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947
[TBL] [Abstract][Full Text] [Related]
3. Cost of exome sequencing in epileptic encephalopathy: is it 'worth it'?
Forman EB; Gorman KM; Conroy J; Arthur N; Grant C; Ennis S; Allen NM; Lynch SA; King MD
Arch Dis Child; 2018 Mar; 103(3):304. PubMed ID: 28939639
[No Abstract] [Full Text] [Related]
4. Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: the China experience.
Hu X; Li N; Xu Y; Li G; Yu T; Yao RE; Fu L; Wang J; Yin L; Yin Y; Wang Y; Jin X; Wang X; Wang J; Shen Y
Genet Med; 2018 Sep; 20(9):1045-1053. PubMed ID: 29095814
[TBL] [Abstract][Full Text] [Related]
5. Exome Sequencing for Isolated Congenital Hearing Loss: A Cost-Effectiveness Analysis.
Downie L; Amor DJ; Halliday J; Lewis S; Martyn M; Goranitis I
Laryngoscope; 2021 Jul; 131(7):E2371-E2377. PubMed ID: 33382469
[TBL] [Abstract][Full Text] [Related]
6. A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis.
Tan TY; Lunke S; Chong B; Phelan D; Fanjul-Fernandez M; Marum JE; Kumar VS; Stark Z; Yeung A; Brown NJ; Stutterd C; Delatycki MB; Sadedin S; Martyn M; Goranitis I; Thorne N; Gaff CL; White SM
Eur J Hum Genet; 2019 Dec; 27(12):1791-1799. PubMed ID: 31320747
[TBL] [Abstract][Full Text] [Related]
7. Whole Exome Sequencing in Pediatric Neurology Patients: Clinical Implications and Estimated Cost Analysis.
Nolan D; Carlson M
J Child Neurol; 2016 Jun; 31(7):887-94. PubMed ID: 26863999
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.
Tan TY; Dillon OJ; Stark Z; Schofield D; Alam K; Shrestha R; Chong B; Phelan D; Brett GR; Creed E; Jarmolowicz A; Yap P; Walsh M; Downie L; Amor DJ; Savarirayan R; McGillivray G; Yeung A; Peters H; Robertson SJ; Robinson AJ; Macciocca I; Sadedin S; Bell K; Oshlack A; Georgeson P; Thorne N; Gaff C; White SM
JAMA Pediatr; 2017 Sep; 171(9):855-862. PubMed ID: 28759686
[TBL] [Abstract][Full Text] [Related]
10. The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study.
Dragojlovic N; Elliott AM; Adam S; van Karnebeek C; Lehman A; Mwenifumbo JC; Nelson TN; du Souich C; Friedman JM; Lynd LD
Genet Med; 2018 Sep; 20(9):1013-1021. PubMed ID: 29300375
[TBL] [Abstract][Full Text] [Related]
11. Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort.
Rochtus A; Olson HE; Smith L; Keith LG; El Achkar C; Taylor A; Mahida S; Park M; Kelly M; Shain C; Rockowitz S; Rosen Sheidley B; Poduri A
Epilepsia; 2020 Feb; 61(2):249-258. PubMed ID: 31957018
[TBL] [Abstract][Full Text] [Related]
12. Use of a Dynamic Genetic Testing Approach for Childhood-Onset Epilepsy.
Balciuniene J; DeChene ET; Akgumus G; Romasko EJ; Cao K; Dubbs HA; Mulchandani S; Spinner NB; Conlin LK; Marsh ED; Goldberg E; Helbig I; Sarmady M; Abou Tayoun A
JAMA Netw Open; 2019 Apr; 2(4):e192129. PubMed ID: 30977854
[TBL] [Abstract][Full Text] [Related]
13. Consecutive medical exome analysis at a tertiary center: Diagnostic and health-economic outcomes.
Kosaki R; Kubota M; Uehara T; Suzuki H; Takenouchi T; Kosaki K
Am J Med Genet A; 2020 Jul; 182(7):1601-1607. PubMed ID: 32369273
[TBL] [Abstract][Full Text] [Related]
14. Clinical next generation sequencing in developmental and epileptic encephalopathies: Diagnostic relevance of data re-analysis and variants re-interpretation.
Salinas V; Martínez N; Maturo JP; Rodriguez-Quiroga SA; Zavala L; Medina N; Amartino H; Sfaello I; Agosta G; Serafín EM; Morón DG; Kauffman MA; Vega P
Eur J Med Genet; 2021 Dec; 64(12):104363. PubMed ID: 34673242
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test.
Thevenon J; Duffourd Y; Masurel-Paulet A; Lefebvre M; Feillet F; El Chehadeh-Djebbar S; St-Onge J; Steinmetz A; Huet F; Chouchane M; Darmency-Stamboul V; Callier P; Thauvin-Robinet C; Faivre L; Rivière JB
Clin Genet; 2016 Jun; 89(6):700-7. PubMed ID: 26757139
[TBL] [Abstract][Full Text] [Related]
16. Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness.
Stark Z; Schofield D; Martyn M; Rynehart L; Shrestha R; Alam K; Lunke S; Tan TY; Gaff CL; White SM
Genet Med; 2019 Jan; 21(1):173-180. PubMed ID: 29765138
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability.
Monroe GR; Frederix GW; Savelberg SM; de Vries TI; Duran KJ; van der Smagt JJ; Terhal PA; van Hasselt PM; Kroes HY; Verhoeven-Duif NM; Nijman IJ; Carbo EC; van Gassen KL; Knoers NV; Hövels AM; van Haelst MM; Visser G; van Haaften G
Genet Med; 2016 Sep; 18(9):949-56. PubMed ID: 26845106
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children.
Aaltio J; Hyttinen V; Kortelainen M; Frederix GWJ; Lönnqvist T; Suomalainen A; Isohanni P
Eur J Paediatr Neurol; 2022 Jan; 36():30-36. PubMed ID: 34852981
[TBL] [Abstract][Full Text] [Related]
19. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology.
Vissers LELM; van Nimwegen KJM; Schieving JH; Kamsteeg EJ; Kleefstra T; Yntema HG; Pfundt R; van der Wilt GJ; Krabbenborg L; Brunner HG; van der Burg S; Grutters J; Veltman JA; Willemsen MAAP
Genet Med; 2017 Sep; 19(9):1055-1063. PubMed ID: 28333917
[TBL] [Abstract][Full Text] [Related]
20. Genetic diagnosis of infantile-onset epilepsy in the clinic: Application of whole-exome sequencing following epilepsy gene panel testing.
Kim SY; Jang SS; Kim H; Hwang H; Choi JE; Chae JH; Kim KJ; Lim BC
Clin Genet; 2021 Mar; 99(3):418-424. PubMed ID: 33349918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]